Vapendavir
Vapendavir (BTA798) is a potent enteroviral capsid binder (CB) . Vapendavir (BTA798) possesses potent antiviral activity for enterovirus 71 (EV71) replication, with EC50 values of 0.5-1.4 μM in different EV71 strains[1][2].
Product Specifications
CAS Number
439085-51-5
Product Name Alternative
BTA798
UNSPSC
12352005
Target
Enterovirus
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/vapendavir.html
Solubility
10 mM in DMSO
Smiles
CCOC1=NOC2=CC(OCCC3CCN(C4=CC=C(C)N=N4)CC3)=CC=C12
Molecular Formula
C21H26N4O3
Molecular Weight
382.46
References & Citations
[1]Tijsma A, et al. The capsid binder Vapendavir and the novel protease inhibitor SG85 inhibit enterovirus 71 replication. Antimicrob Agents Chemother. 2014 Nov;58 (11) :6990-2.|[2]Sun L, et al. Antiviral Activity of Broad-Spectrum and Enterovirus-Specific Inhibitors against Clinical Isolates of Enterovirus D68. Antimicrob Agents Chemother. 2015 Dec;59 (12) :7782-5.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Citation 01
ACS Infect Dis. 2020 May 8;6 (5) :882-890.|SSRN. 2024 Apr 19.|Eur J Med Chem. 2025 Feb 14:288:117395.|Norwegian University of Science and Technology. 2023 May.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2918490-01 20 µg
Recombinant Escherichia coli O17:K52:H18 Glycerol-3-phosphate acyltransferase (plsY)
Sign In for Pricing
View Details orb2918490-02 100 µg
Recombinant Escherichia coli O17:K52:H18 Glycerol-3-phosphate acyltransferase (plsY)
Sign In for Pricing
View Details 